We are live on
!
Find out more
PCP
Pacific Capital Partners Portfolio holdings
AUM
$116M
1-Year Est. Return
24.59%
This Fund
S&P 500
This Quarter
Est. Return
-2.82%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$7.19M
(+7.6%)
Cap. Flow
+$11.9M
Cap. Flow
% of AUM
11.79%
Top 10 Holdings %
Top 10 Hldgs %
58.17%
Holding
65
New
29
Increased
7
Reduced
2
Closed
27
Avg Time Held
0.5
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$7.18M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$6.63M |
| 3 |
Advanced Micro Devices
AMD
|
+$4.9M |
| 4 |
NVIDIA
NVDA
|
+$4.62M |
| 5 |
AutoZone
AZO
|
+$4.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$6.24M |
| 2 |
CRH
CRH
|
+$5.46M |
| 3 |
Avantor
AVTR
|
+$4.86M |
| 4 |
AerCap
AER
|
+$4.71M |
| 5 |
EPAM Systems
EPAM
|
+$4.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.07% |
| 2 | Technology | 19.83% |
| 3 | Communication Services | 14.18% |
| 4 | Industrials | 11.95% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
51
EPAM Systems
EPAM
$5.65B
| – | – |
-20,250
| Closed | -$4.15M | – |
|
52
Fortive
FTV
$17.4B
| – | – |
-32,500
| Closed | -$1.79M | – |
|
53
Humana
HUM
$48B
| – | – |
-13,500
| Closed | -$3.46M | – |
|
54
ICU Medical
ICUI
$4.06B
| – | – |
-17,750
| Closed | -$2.53M | – |
|
55
KKR & Co
KKR
$80.8B
| – | – |
-10,750
| Closed | -$1.37M | – |
|
56
Standard BioTools
LAB
$306M
| – | – |
-475,000
| Closed | -$608K | – |
|
57
Louisiana-Pacific
LPX
$4.62B
| – | – |
-12,500
| Closed | -$1.01M | – |
|
58
MetLife
MET
$61.7B
| – | – |
-19,250
| Closed | -$1.52M | – |
|
59
nCino
NCNO
$2.03B
| – | – |
-37,500
| Closed | -$962K | – |
|
60
Prestige Consumer Healthcare
PBH
$2.15B
| – | – |
-5,000
| Closed | -$308K | – |
|
61
PayPal
PYPL
$46.2B
| – | – |
-50,500
| Closed | -$2.95M | – |
|
62
Royalty Pharma
RPRX
$25B
| – | – |
-94,750
| Closed | -$3.66M | – |
|
63
Sensient Technologies
SXT
$5.54B
| – | – |
-5,000
| Closed | -$470K | – |
|
64
UnitedHealth
UNH
$336B
| – | – |
-11,750
| Closed | -$3.88M | – |
|
65
Woodward
WWD
$19.8B
| – | – |
-2,500
| Closed | -$756K | – |
|
Similar funds
VWA
JBC
IIWM
JBI
BWM
SAM
ACA
VFM
Pacific Capital Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Pacific Capital Partners held 65 positions worth $101M, up 7.6% from $94.2M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Pacific Capital Partners deployed $11.9M of net new capital in Q1 2026, opening 29 new positions and adding to 7 existing holdings. Its largest new stake was Progressive: 34,784 shares worth $6.9M.
By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Becton Dickinson, an estimated $3.85M trimmed.
- Pacific Capital Partners's largest Q1 2026 buy was Progressive: 34,784 shares worth $6.9M.
- Pacific Capital Partners added most to Berkshire Hathaway Class A in Q1 2026, an estimated $6.63M increase.
- Pacific Capital Partners's biggest Q1 2026 reduction was Becton Dickinson, cutting an estimated $3.85M.
- Pacific Capital Partners fully exited Danaher in Q1 2026, selling an estimated $6.24M.
- Pacific Capital Partners's ten largest holdings make up 58% of its $101M portfolio in Q1 2026.
- Pacific Capital Partners opened 29 new positions and closed 27 in Q1 2026.
- Pacific Capital Partners's portfolio value rose 7.6% quarter-over-quarter to $101M.
Based on Pacific Capital Partners's 13F filing for Q1 2026, filed 9 Apr 2026.